22nd Century Group’s (XXII) “Sell (E+)” Rating Reaffirmed at Weiss Ratings

22nd Century Group (NASDAQ:XXII)‘s stock had its “sell (e+)” rating restated by analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Separately, StockNews.com downgraded 22nd Century Group from a “hold” rating to a “sell” rating in a report on Tuesday, December 31st.

22nd Century Group Stock Performance

XXII stock opened at $3.25 on Wednesday. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. The business has a 50-day moving average price of $4.89 and a 200 day moving average price of $23.35. The company has a market capitalization of $5.58 million, a P/E ratio of 0.00 and a beta of 1.57. 22nd Century Group has a 1-year low of $3.01 and a 1-year high of $581.85.

Institutional Trading of 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP bought a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned approximately 6.77% of 22nd Century Group as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 18.06% of the company’s stock.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.